SCHEMBL15071846

SCHEMBL15071846

CCc1ccc(Cc2ccc(CP)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.43
TAAR1 Q96RJ0 1/20 0.42
CYP2A6 P11509 1/20 0.41
LPL P06858 1/20 0.41
LIPG Q9Y5X9 1/20 0.41
PLK1 P53350 1/20 0.40
ALDH1A1 P00352 3/20 0.39
TSHR P16473 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
MAPK1 P28482 2/20 0.39
CYP3A4 P08684 2/20 0.39
CA2 P00918 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
PLAU P00749 1/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2491352 0.86 TP53 (0.56) TP53TAAR1CYP2A6LPLLIPG
SCHEMBL14174580 0.86 ALDH1A1 (0.47) TP53ALDH1A1TSHRTDP1MAPK1
SCHEMBL15071844 0.86 ALDH1A1 (0.47) TP53ALDH1A1TSHRTDP1MAPK1
SCHEMBL10024804 0.80 TAAR1 (0.50) TP53TAAR1CYP2A6LPLLIPG
SCHEMBL20412549 0.79 IDO1 (0.46) TAAR1CYP2A6ALDH1A1TSHRTDP1
SCHEMBL13687805 0.79 IDO1 (0.46) TAAR1CYP2A6ALDH1A1TSHRTDP1
SCHEMBL5946305 0.76 ESR1 (0.32) ALDH1A1TSHRTDP1CYP3A4ESR1
SCHEMBL36295 0.76 TP53 (0.67) TP53TAAR1CYP2A6LPLLIPG
SCHEMBL12990789 0.76 ALDH1A1 (0.39) TP53ALDH1A1TSHRTDP1MAPK1
SCHEMBL5031564 0.76 TP53 (0.78) TP53TAAR1CYP2A6ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9770515-B2 Crosslinking of proteins and other entities via conjugates of α-haloacetophenones, benzyl halides, quinones, and their derivatives ADVANCED PROTEOME THERAPEUTICS INC. (US) 2017-09-26 US disclosed
US-20130165382-A1 CROSSLINKING OF PROTEINS AND OTHER ENTITIES VIA CONJUGATES OF ALPHA-HALOACETOPHENONES, BENZYL HALIDES, QUINONES, AND THEIR DERIVATIVES ADVANCED PROTEOME THERAPEUTICS INC. (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165382-A1 CROSSLINKING OF PROTEINS AND OTHER ENTITIES VIA CONJUGATES OF ALPHA-HALOACETOPHENONES, BENZYL HALIDES, QUINONES, AND THEIR DERIVATIVES TBCA, HSP90AB2P, HSP90B1 TP53 2106/4885TAAR1 3684/4885CYP2A6 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.